Skandinaviska Enskilda Banken (SEB)
KYNB

Skandinaviska Enskilda Banken (SEB)’s Kyntra Bio KYNB Stock Holding History

Skandinaviska Enskilda Banken (SEB)’s Portfolio KYNB Stock Details KYNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-456
Closed -$31K – 947
2023
Q2 		$31K Buy
+456
New +$189K ﹤0.01% 926
2021
Q2 		– Sell
-684
Closed -$593K – 1074
2021
Q1 		$593K Buy
+684
New +$728K ﹤0.01% 903

Other funds holding KYNB

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Skandinaviska Enskilda Banken (SEB)'s KYNB Position: Q3 2023 in Review

Skandinaviska Enskilda Banken (SEB) sold out of Kyntra Bio (KYNB) in Q3 2023, closing a stake of 456 shares — an estimated $31K sold.

Skandinaviska Enskilda Banken (SEB) first reported a position in KYNB in Q1 2021 and held it in 2 quarters. The position peaked at $593K in Q1 2021. 110 funds tracked by Wall St. Rank hold KYNB as of Q3 2023.

  • Skandinaviska Enskilda Banken (SEB) reported no remaining Kyntra Bio position as of Q3 2023 after selling out during the quarter.
  • Skandinaviska Enskilda Banken (SEB) sold 456 Kyntra Bio shares in Q3 2023, an estimated $31K.
  • Skandinaviska Enskilda Banken (SEB) first reported a position in Kyntra Bio in Q1 2021 and held it in 2 quarters.
  • Skandinaviska Enskilda Banken (SEB)'s Kyntra Bio position peaked at $593K in Q1 2021.
  • 110 funds tracked by Wall St. Rank held Kyntra Bio as of Q3 2023.

Based on Skandinaviska Enskilda Banken (SEB)'s 13F filing for Q3 2023, filed 9 Nov 2023.